发明公开
EP2077120A2 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient
失效
风湿性关节炎关节炎IL-6拮抗剂Aktivsubstanz
- 专利标题： Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient
- 专利标题（中）： 风湿性关节炎关节炎IL-6拮抗剂Aktivsubstanz
-
申请号： EP09000787.3申请日： 1995-06-07
-
公开(公告)号： EP2077120A2公开(公告)日： 2009-07-08
- 发明人: Kishimoto, Tadamitsu , Mihara, Masahiko , Moriya, Yoichiro , Ohsugi, Yoshijuki
- 申请人： Chugai Seiyaku Kabushiki Kaisha , Kishimoto, Tadamitsu
- 申请人地址： 5-1, 5-chome, Ukima Kita-ku Tokyo 115 JP
- 专利权人： Chugai Seiyaku Kabushiki Kaisha,Kishimoto, Tadamitsu
- 当前专利权人： Chugai Seiyaku Kabushiki Kaisha,Kishimoto, Tadamitsu
- 当前专利权人地址： 5-1, 5-chome, Ukima Kita-ku Tokyo 115 JP
- 代理机构： Vossius & Partner
- 优先权： JP24403594 19941007
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61K38/20 ; C12P21/08 ; C12R1/46 ; C07K16/24
摘要：
There is provided a synovial cell growth inhibitor, or a pharmaceutical composition for treatment of chronic rheumatoid arthritis based on the synovial cell growth inhibitor.
The pharmaceutical composition for treatment of chronic rheumatoid arthritis or synovial cell growth inhibitor contains an IL-6 antagonist, such as IL-6 antibody or IL-6R antibody, as an effective component.
The pharmaceutical composition for treatment of chronic rheumatoid arthritis or synovial cell growth inhibitor contains an IL-6 antagonist, such as IL-6 antibody or IL-6R antibody, as an effective component.
公开/授权文献
信息查询
